German Pharmacoepidemiological Research Database (GePaRD)
The research data centre FDZ GePaRD (German Pharmacoepidemiological Research Database) is a pharmacoepidemiological research database with data from statutory health insurance providers in Germany. Since 2004, the Leibniz Institute for Prevention Research and Epidemiology – BIPS has been working on the establishment and maintenance of GePaRD, which can be used to investigate research questions on the utilization and safety of drugs and vaccines in routine care.
- Thematic Focus: Health
- Data type focus: Both Equally
- Status: Preliminary
- External Data Ingest: No
- RDM Consultation: No
Data Offer
- Claims data from four statutory health insurance (SHI) providers in Germany
- Information on approximately 25 million persons who have been insured with one of the participating providers since 2004 or later
- Demographic data
- Information on drug dispensations as well as outpatient (i.e., from general practitioners and specialists) and inpatient services and diagnoses
- Per data year: information on approximately 20% of the general population
- All geographical regions of Germany represented
- Process from data delivery and preparation to availability of data for analyses: ca. 24 months
Services
Detailed descriptions of the data set are available on a designated internal website and are made available to GePaRD users as online material. A condensed work aid for the determination of prevalences is also provided.
In addition, a rough description is posted on the BIPS homepage to inform potential users about the dataset. This dataset description is also supplemented by brief descriptions of example applications to show the potential range of applications. In addition, the limitations are pointed out explicitly.
Data Access Mode
Access to the database is granted only to BIPS employees within the framework of officially approved research projects. It is only permitted to give third parties access to the data in cooperation with BIPS and after signing an agreement for visiting scientists. Project approval is based on the authorization by the SHI providers and the respective governing authorities (e.g., the Federal Office for Social Security for national SHI providers). For this purpose, BIPS applies for project-specific permits from the SHI providers. Upon approval, the SHI provider requests official project approval from the governing authority. This may be issued in accordance with Section 75 of the German Social Code (SGB) X if the interest warranting protection of the person concerned is not affected or if the public interest in the research or planning significantly outweighs the interest in personal privacy.
Contact
Leibniz Institute for Prevention Research and Epidemiology – BIPS
Achterstr. 30
D-28359 Bremen
Phone: +49 421 218-56860
E-Mail: gepard@leibniz-bips.de